SG11201408093PA - Amides of 2-amino-4-arylthiazole compounds and their salts - Google Patents
Amides of 2-amino-4-arylthiazole compounds and their saltsInfo
- Publication number
- SG11201408093PA SG11201408093PA SG11201408093PA SG11201408093PA SG11201408093PA SG 11201408093P A SG11201408093P A SG 11201408093PA SG 11201408093P A SG11201408093P A SG 11201408093PA SG 11201408093P A SG11201408093P A SG 11201408093PA SG 11201408093P A SG11201408093P A SG 11201408093PA
- Authority
- SG
- Singapore
- Prior art keywords
- maharashtra
- sector
- international
- mumbai
- navi
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title abstract 3
- 150000001408 amides Chemical class 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 abstract 2
- 240000003492 Neolamarckia cadamba Species 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1687MU2012 | 2012-06-08 | ||
| US201261665282P | 2012-06-27 | 2012-06-27 | |
| IN3519MU2012 | 2012-12-13 | ||
| US201261748016P | 2012-12-31 | 2012-12-31 | |
| PCT/IB2013/054703 WO2013183035A2 (en) | 2012-06-08 | 2013-06-08 | Amides of 2-amino-4-arylthiazole compounds and their salts |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201408093PA true SG11201408093PA (en) | 2015-01-29 |
Family
ID=54193746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201408093PA SG11201408093PA (en) | 2012-06-08 | 2013-06-08 | Amides of 2-amino-4-arylthiazole compounds and their salts |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US9458173B2 (cs) |
| EP (1) | EP2858999B1 (cs) |
| JP (1) | JP5989900B2 (cs) |
| KR (1) | KR20150015488A (cs) |
| CN (1) | CN104350058A (cs) |
| AP (1) | AP3546A (cs) |
| AU (1) | AU2013273118B2 (cs) |
| BR (1) | BR112014029155A2 (cs) |
| CA (1) | CA2873570C (cs) |
| CL (1) | CL2014003317A1 (cs) |
| EA (1) | EA031334B1 (cs) |
| HK (1) | HK1207643A1 (cs) |
| IL (1) | IL236084A0 (cs) |
| IN (1) | IN2014MN02467A (cs) |
| MX (1) | MX354014B (cs) |
| MY (1) | MY165622A (cs) |
| NZ (1) | NZ701721A (cs) |
| PE (1) | PE20142306A1 (cs) |
| PH (1) | PH12014502685A1 (cs) |
| SG (1) | SG11201408093PA (cs) |
| WO (1) | WO2013183035A2 (cs) |
| ZA (1) | ZA201500082B (cs) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2861604T (pt) | 2012-06-08 | 2017-05-05 | Gilead Sciences Inc | Inibidores macrocíclicos de vírus flaviridae |
| AR091279A1 (es) | 2012-06-08 | 2015-01-21 | Gilead Sciences Inc | Inhibidores macrociclicos de virus flaviviridae |
| AU2014282762B2 (en) | 2013-06-20 | 2016-11-10 | Ichnos Sciences SA | Nanoparticulate formulation comprising a TRPA1 antagonist |
| JP6573968B2 (ja) * | 2014-08-11 | 2019-09-11 | ハイドラ バイオサイエンシズ インコーポレイテッドＨｙｄｒａ Ｂｉｏｓｃｉｅｎｃｅｓ，Ｉｎｃ． | ＴＲＰＣ５調節因子としての、精神神経障害の処置のためのチエノおよびフロ［２，３−ｄ］ピリミジン−２，４［１Ｈ，３Ｈ］−ジオン誘導体 |
| WO2016042501A1 (en) * | 2014-09-16 | 2016-03-24 | Glenmark Pharmaceuticals S.A. | Trpa1 antagonist for the treatment of pain associated to diabetic neuropathic pain |
| TW202321229A (zh) | 2021-08-18 | 2023-06-01 | 美商富曼西公司 | 殺真菌的取代的雜環化合物 |
| CN114671875A (zh) * | 2022-04-27 | 2022-06-28 | 成都施贝康生物医药科技有限公司 | 新型二氢嘧啶类化合物、异构体或盐及其制备方法和用途 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2248231A1 (de) | 1972-10-02 | 1974-04-11 | Basf Ag | 3-aminoisothiazolo eckige klammer auf 3,4-d eckige klammer zu pyrimidine |
| SE9701398D0 (sv) | 1997-04-15 | 1997-04-15 | Astra Pharma Prod | Novel compounds |
| ES2193839B1 (es) | 2001-06-22 | 2005-02-16 | Almirall Prodesfarma, S.A. | Nuevos derivados de 6-fenildihidropirrolpirimidindiona. |
| WO2004014916A1 (en) * | 2002-08-13 | 2004-02-19 | Warner-Lambert Company Llc | Pyrimidine fused bicyclic metalloproteinase inhibitors |
| US6890923B2 (en) | 2002-12-16 | 2005-05-10 | Astrazeneca Ab | Compounds |
| WO2004055054A1 (en) | 2002-12-18 | 2004-07-01 | Novartis Ag | Anktm1, a cold-activated trp-like channel expressed in nociceptive neurons |
| EP1657238A4 (en) | 2003-08-22 | 2008-12-03 | Takeda Pharmaceutical | CONDENSATE PYRIMIDINE DERIVATIVE AND ITS USE |
| WO2005077959A1 (en) | 2004-02-11 | 2005-08-25 | Smithkline Beecham Corporation | Pth agonists |
| WO2005089206A2 (en) | 2004-03-13 | 2005-09-29 | Irm Llc | Modulators of ion channel trpa1 |
| US20090062258A1 (en) | 2005-02-03 | 2009-03-05 | Takeda Pharmaceutical Company Limited | Fused pyrimidine derivative and use thereof |
| US20070032531A1 (en) | 2005-08-04 | 2007-02-08 | Apogee Biotechnology Corporation | Sphingosine kinase inhibitors and methods of their use |
| US20070105920A1 (en) | 2005-11-08 | 2007-05-10 | Akzo Nobel N.V. | 2-(Benzimidazol-1-Yl)-N-(4-phenylthiazol-2-yl) acetamide derivatives |
| ES2436225T3 (es) | 2005-12-22 | 2013-12-27 | Hydra Biosciences, Inc. | Inhibidores TRPA1 para tratamiento del dolor |
| CN101454318A (zh) * | 2006-03-22 | 2009-06-10 | 阿斯利康(瑞典)有限公司 | 吡啶并嘧啶衍生物及其作为pde4抑制剂的用途 |
| TW200800997A (en) | 2006-03-22 | 2008-01-01 | Astrazeneca Ab | Chemical compounds |
| JP2011201776A (ja) | 2008-07-23 | 2011-10-13 | Mochida Pharmaceut Co Ltd | ヘテロシクリデン−ｎ−（３，４−ジヒドロ−２（１ｈ）−キナゾリノン−５−イル）アセトアミド誘導体 |
| WO2008094909A2 (en) | 2007-01-29 | 2008-08-07 | Xenon Pharmaceuticals Inc. | Quinazolinone and fused pyrimidinone compounds and their use in treating sodium channel-mediated diseases or conditions |
| CN101801362B (zh) * | 2007-06-22 | 2014-01-22 | 海德拉生物科学公司 | 用于治疗病症的方法和组合物 |
| WO2010004390A1 (en) * | 2008-06-17 | 2010-01-14 | Glenmark Pharmaceuticals, S.A. | Quinazoline dione derivatives as trpa1 modulators |
| WO2009158719A2 (en) | 2008-06-27 | 2009-12-30 | Hydra Biosciences, Inc. | Methods and compositions for treating disorders |
| US8623880B2 (en) | 2009-03-23 | 2014-01-07 | Glenmark Pharmaceuticals S.A. | Fused pyrimidine-dione derivatives as TRPA1 modulators |
| EP2708538B1 (en) | 2009-03-23 | 2015-08-12 | Glenmark Pharmaceuticals S.A. | Process for preparing fused pyrimidine-dione derivatives, useful as as TRPA1 modulators |
| SG174403A1 (en) | 2009-03-23 | 2011-10-28 | Glenmark Pharmaceuticals Sa | Isothiazolo-pyrimidinedione derivatives as trpa1 modulators |
| DK2411395T3 (da) * | 2009-03-23 | 2013-08-05 | Glenmark Pharmaceuticals Sa | Furopyrimidindionderivater som modulatorer for TRPA1 |
| AR084294A1 (es) | 2010-12-20 | 2013-05-08 | Glenmark Pharmaceuticals Sa | Compuestos de 2-amino-4-ariltiazol, metodos para su sintesis y uso como antagonista de trpa1 |
-
2013
- 2013-06-08 CA CA2873570A patent/CA2873570C/en active Active
- 2013-06-08 SG SG11201408093PA patent/SG11201408093PA/en unknown
- 2013-06-08 AU AU2013273118A patent/AU2013273118B2/en not_active Ceased
- 2013-06-08 AP AP2014008076A patent/AP3546A/xx active
- 2013-06-08 BR BR112014029155A patent/BR112014029155A2/pt not_active Application Discontinuation
- 2013-06-08 JP JP2015515642A patent/JP5989900B2/ja not_active Expired - Fee Related
- 2013-06-08 MY MYPI2014003389A patent/MY165622A/en unknown
- 2013-06-08 CN CN201380030184.XA patent/CN104350058A/zh active Pending
- 2013-06-08 EA EA201492054A patent/EA031334B1/ru unknown
- 2013-06-08 US US14/402,608 patent/US9458173B2/en not_active Expired - Fee Related
- 2013-06-08 PE PE2014002226A patent/PE20142306A1/es not_active Application Discontinuation
- 2013-06-08 KR KR1020147033855A patent/KR20150015488A/ko not_active Abandoned
- 2013-06-08 NZ NZ701721A patent/NZ701721A/en not_active IP Right Cessation
- 2013-06-08 HK HK15108333.2A patent/HK1207643A1/xx unknown
- 2013-06-08 IN IN2467MUN2014 patent/IN2014MN02467A/en unknown
- 2013-06-08 WO PCT/IB2013/054703 patent/WO2013183035A2/en active Application Filing
- 2013-06-08 MX MX2014014482A patent/MX354014B/es active IP Right Grant
- 2013-06-08 EP EP13742279.6A patent/EP2858999B1/en active Active
-
2014
- 2014-12-02 PH PH12014502685A patent/PH12014502685A1/en unknown
- 2014-12-04 CL CL2014003317A patent/CL2014003317A1/es unknown
- 2014-12-04 IL IL236084A patent/IL236084A0/en unknown
-
2015
- 2015-01-07 ZA ZA2015/00082A patent/ZA201500082B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL236084A0 (en) | 2015-02-01 |
| NZ701721A (en) | 2016-03-31 |
| MX354014B (es) | 2018-02-08 |
| CN104350058A (zh) | 2015-02-11 |
| WO2013183035A3 (en) | 2014-02-27 |
| PH12014502685B1 (en) | 2015-01-26 |
| US20150111038A1 (en) | 2015-04-23 |
| MY165622A (en) | 2018-04-18 |
| CL2014003317A1 (es) | 2015-02-13 |
| IN2014MN02467A (cs) | 2015-07-10 |
| AP3546A (en) | 2016-01-14 |
| WO2013183035A2 (en) | 2013-12-12 |
| JP2015520183A (ja) | 2015-07-16 |
| PE20142306A1 (es) | 2015-01-16 |
| AU2013273118B2 (en) | 2015-11-05 |
| MX2014014482A (es) | 2015-06-05 |
| EA031334B1 (ru) | 2018-12-28 |
| PH12014502685A1 (en) | 2015-01-26 |
| CA2873570A1 (en) | 2013-12-12 |
| ZA201500082B (en) | 2015-12-23 |
| US9458173B2 (en) | 2016-10-04 |
| EP2858999A2 (en) | 2015-04-15 |
| EP2858999B1 (en) | 2017-05-10 |
| EA201492054A1 (ru) | 2016-08-31 |
| HK1207643A1 (en) | 2016-02-05 |
| JP5989900B2 (ja) | 2016-09-07 |
| KR20150015488A (ko) | 2015-02-10 |
| BR112014029155A2 (pt) | 2017-06-27 |
| CA2873570C (en) | 2016-11-01 |
| AP2014008076A0 (en) | 2014-11-30 |
| AU2013273118A1 (en) | 2014-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201408093PA (en) | Amides of 2-amino-4-arylthiazole compounds and their salts | |
| SG11201808729WA (en) | Bet protein degraders | |
| SG11201407458XA (en) | TRIAZOLONE COMPOUNDS AS mPGES-1 INHIBITORS | |
| SG11201901715UA (en) | Adenovirus armed with bispecific t cell engager (bite) | |
| SG11201808728QA (en) | Mdm2 protein degraders | |
| SG11201408750VA (en) | NOVEL FUSED PYRIDINE DERIVATIVES USEFUL AS c-MET TYROSINE KINASE INHIBITORS | |
| SG11201805838UA (en) | Macrocyclic mcl1 inhibitors for treating cancer | |
| SG11201809132RA (en) | Novel compounds as autotaxin inhibitors and pharmaceutical compositions comprising the same | |
| SG11201407682TA (en) | Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators | |
| SG11201408140QA (en) | Crystalline forms of an androgen receptor modulator | |
| SG11201408186TA (en) | Pyridinone and pyridazinone derivatives | |
| SG11201909807TA (en) | Methods of manufacturing of niraparib | |
| SG11201803993XA (en) | Narrow band prach with multiple tone hopping distances | |
| SG11201408133TA (en) | Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases | |
| SG11201901457TA (en) | 2'-substituted-n6-substituted purine nucleotides for rna virus treatment | |
| SG11201408303WA (en) | Adhesive compositions of propylene-based and ethylene-based polymers | |
| SG11201407402TA (en) | Carbazole-containing sulfonamides as cryptochrome modulators | |
| SG11201408037SA (en) | Humanized anti-trka antibodies with amino acid substitutions | |
| SG11201408198QA (en) | Jumper tube locking assembly and method | |
| SG11201407988UA (en) | Process for improved opioid synthesis | |
| SG11201408119PA (en) | Systems and methods for data center cooling and water desalination | |
| SG11201408297XA (en) | Porous graphene oxide materials | |
| SG11201900408RA (en) | Topical formulation for promoting wound healing | |
| SG11201903091VA (en) | Quinoxaline compounds as type iii receptor tyrosine kinase inhibitors | |
| SG11201809560QA (en) | Enhancer of zeste homolog 2 inhibitors |